Back to Directory

Elizabeth Rivas

Email

erivas@fhi360.org

Phone

1 919-321-3890

Institution

FHI 360

Address

FHI 360
359 Blackwell Street, Suite 200
Durham, NC 27701
USA

Request an Update

Affiliated Studies

IMPAACT 2039A: Phase I Study of the Safety and Immunogenicity of HIVconsvX Vaccines and the Safety and Pharmacokinetics of Broadly Neutralizing Antibodies in Children Living with HIV

DAIDS Number

Research Area

Cure and Immunotherapy

Study Status

IMPAACT 2047: Radiant-Moms Plus

DAIDS Number

Research Area

Study Status

IMPAACT 2026: Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum.

DAIDS Number

Research Area

Study Status

Closed to Accrual

IMPAACT 2035/HVTN 604: Phase I/II Randomized, Placebo-Controlled Study of the Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination against Tuberculosis in Pre-Adolescents Living with and without HIV in South Africa (LEAP)

DAIDS Number

Research Area

Study Status

IMPAACT 2039: EXCEED

DAIDS Number

Research Area

Cure and Immunotherapy

Study Status